Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy-Reference-Cited by-同舟云学术

Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy

Published:2013-06-14 Issue:2 Volume:55 Page:288-295
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Wahlin Björn Engelbrekt,Sundström Christer,Sander Birgitta,Christensson Birger,Jeppsson-Ahlberg Åsa,Hjalmarsson Eric,Holte Harald,Østenstad Bjørn,Brown Peter D.,Smeland Erlend Bremertun,Kimby Eva

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2013.802778

Reference44 articles.

1. New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

2. Follicular Lymphoma in the United States: First Report of the National LymphoCare Study

3. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial

4. Long-Term Follow-Up of Patients With Follicular Lymphoma Receiving Single-Agent Rituximab at Two Different Schedules in Trial SAKK 35/98

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Follicular lymphoma and marginal zone lymphoma: how many diseases?;Virchows Archiv;2022-11-17

2. Prognostic significance of histologic grade and Ki‐67 proliferation index in follicular lymphoma;Hematological Oncology;2020-09-10

3. Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy;Annals of Hematology;2020-08-17

4. Clinical and Biological Prognostic Factors in Follicular Lymphoma;Hematology/Oncology Clinics of North America;2020-08

5. Low initial trough concentration of rituximab is associated with unsatisfactory response of first-line R-CHOP treatment in patients with follicular lymphoma with grade 1/2;Acta Pharmacologica Sinica;2020-07-31